Immutep (IMMP) Other Working Capital Changes (2011 - 2024)
Immutep's (IMMP) quarterly Other Working Capital Changes came in at $1.8 million in Q2 2024, up 330.01% YoY from $412047.0 in Q3 2023, and up 330.01% on a QoQ basis from -$770327.5 in Q2 2023.
Immutep (IMMP) Other Working Capital Changes (2011 - 2024) Analysis & Trends
Immutep (IMMP) has 9 years of Other Working Capital Changes data on file, last reported at $1.8 million in Q2 2024.
- Quarterly Other Working Capital Changes rose 330.01% year-over-year to $1.8 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $1.1 million (up 187.52% YoY) and the FY2024 annual result came in at $1.8 million, up 330.01% from the prior year.
- Other Working Capital Changes improved to $1.8 million in Q2 2024, from -$770327.5 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.8 million in Q2 2024 to a low of -$770327.5 in Q2 2023.
- A 3-year average of $387059.7 and a median of $159648.0 in 2020 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2020 — Other Working Capital Changes surged 617.38% — and 2024, when it soared 330.01%.
- Tracing IMMP's Other Working Capital Changes over 3 years: stood at $159648.0 in 2020, then tumbled by 582.52% to -$770327.5 in 2023, then soared by 330.01% to $1.8 million in 2024.
- The last three Other Working Capital Changes figures came in at $1.8 million (Q2 2024), -$770327.5 (Q2 2023), and $159648.0 (Q2 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Immutep | 56.70 Mn | -8.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Jun 30, 2023 | -770,327.52 |
| Jun 30, 2023 | -770,327.52 |
| Jun 30, 2023 | -770,327.52 |
| Jun 30, 2020 | 159,648.01 |
| Jun 30, 2020 | 159,648.01 |
| Jun 30, 2020 | 159,648.01 |
| Jun 30, 2019 | -30,857.20 |
| Jun 30, 2019 | -30,857.20 |
| Jun 30, 2019 | -30,857.20 |
| Jun 30, 2017 | -649,980.98 |
| Jun 30, 2017 | -649,980.98 |
| Jun 30, 2017 | -649,980.98 |
| Jun 30, 2016 | 242,665.59 |
| Jun 30, 2016 | 242,665.59 |
| Jun 30, 2016 | 242,665.59 |
| Jun 30, 2015 | 272,852.08 |
| Jun 30, 2015 | 272,852.08 |